BiDil for Heart Failure
BiDil (NitroMed), a fixed-dose combination of isosorbide dinitrate and hydralazine, was approved by the FDA for adjunctive use in the treatment of heart failure in black patients.Both drugs are oral vasodilators that have been used together off-label for many years to treat heart failure in patients not responding to other drugs....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: BiDil for Heart Failure
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1218
Article Code: 1218a
Date: September 28, 2005
Volume: 47
Pages: 77-78
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1218
Article Code: 1218a
Date: September 28, 2005
Volume: 47
Pages: 77-78
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)